371 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Reward-Related Striatal Responses Following Stress in Healthy Individuals and Patients With Bipolar Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471186 DOI: 10.1016/j.bpsc.2019.06.014  0.92
2019 de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, ... ... Kahn RS, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biological Psychiatry. PMID 31443932 DOI: 10.1016/j.biopsych.2019.03.985  0.68
2019 de Lange SC, Scholtens LH, van den Berg LH, Boks MP, Bozzali M, Cahn W, Dannlowski U, Durston S, Geuze E, van Haren NEM, Hillegers MHJ, Koch K, Jurado MÁ, Mancini M, ... ... Kahn RS, et al. Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders. Nature Human Behaviour. PMID 31384023 DOI: 10.1038/s41562-019-0659-6  0.68
2019 Pandit R, Cianci D, Ter Hark SE, Winter-van Rossum I, Ebdrup BH, Broberg BV, Garcia-Portilla MP, Bobes J, Vinkers CH, Kahn RS, Guloksuz S, Huitema ADR, Luykx JJ. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort). Acta Psychiatrica Scandinavica. PMID 31323113 DOI: 10.1111/acps.13074  0.6
2019 van den Heuvel MP, Scholtens LH, Kahn RS. Multiscale Neuroscience of Psychiatric Disorders. Biological Psychiatry. PMID 31320130 DOI: 10.1016/j.biopsych.2019.05.015  0.56
2019 Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, Power RA, Ripke S, Stahl EA, Starnawska A, Anjorin A, Corvin A, Sanders AR, Forstner AJ, ... ... Kahn RS, et al. GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores. The American Journal of Psychiatry. appiajp201918080957. PMID 31164008 DOI: 10.1176/appi.ajp.2019.18080957  0.68
2019 He Y, de Witte LD, Houtepen LC, Nispeling DM, Xu Z, Yu Q, Yu Y, Hol EM, Kahn RS, Boks MP. DNA methylation changes related to nutritional deprivation: a genome-wide analysis of population and in vitro data. Clinical Epigenetics. 11: 80. PMID 31097004 DOI: 10.1186/s13148-019-0680-7  0.6
2019 van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhé HG, de Haan L, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, ... ... Kahn RS, et al. Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling. Schizophrenia Research. PMID 31047723 DOI: 10.1016/j.schres.2019.04.011  0.68
2019 Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Kahn RS, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/s41588-019-0397-8  0.6
2019 Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30975584 DOI: 10.1016/j.euroneuro.2019.03.010  1
2019 Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP. Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. Schizophrenia Bulletin. PMID 30926985 DOI: 10.1093/schbul/sbz014  0.56
2019 Nuninga JO, Mandl RCW, Boks MP, Bakker S, Somers M, Heringa SM, Nieuwdorp W, Hoogduin H, Kahn RS, Luijten P, Sommer IEC. Volume increase in the dentate gyrus after electroconvulsive therapy in depressed patients as measured with 7T. Molecular Psychiatry. PMID 30867562 DOI: 10.1038/s41380-019-0392-6  0.6
2019 Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS. Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings. Neuroimage. Clinical. 101656. PMID 30660663 DOI: 10.1016/j.nicl.2019.101656  0.68
2019 Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN. Structural thalamo-frontal hypoconnectivity is related to oculomotor corollary discharge dysfunction in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30630882 DOI: 10.1523/JNEUROSCI.1473-18.2019  0.68
2018 de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM. Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 30597053 DOI: 10.1093/schbul/sby182  0.68
2018 Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, et al. Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study. Psychiatry Research. 271: 421-427. PMID 30537664 DOI: 10.1016/j.psychres.2018.11.071  0.68
2018 Stiekema APM, Islam MA, Liemburg EJ, Castelein S, van den Heuvel ER, van Weeghel J, Aleman A, Bruggeman R, van der Meer L, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, ... ... Kahn RS, et al. Corrigendum to "Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder" [Schizophr. Res. 193 (2018) 173-181]. Schizophrenia Research. PMID 30314649 DOI: 10.1016/j.schres.2018.10.003  0.68
2018 van Bergen AH, Verkooijen S, Vreeker A, Abramovic L, Hillegers MH, Spijker AT, Hoencamp E, Regeer EJ, Knapen SE, Riemersma-van der Lek RF, Schoevers R, Stevens AW, Schulte PFJ, Vonk R, Hoekstra R, ... ... Kahn RS, et al. The characteristics of psychotic features in bipolar disorder. Psychological Medicine. 1-13. PMID 30303059 DOI: 10.1017/S0033291718002854  0.6
2018 Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH. Glucocorticoid receptor exon 1 methylation and the cortisol stress response in health and disease. Psychoneuroendocrinology. 97: 182-189. PMID 30036796 DOI: 10.1016/j.psyneuen.2018.07.018  0.6
2018 Minică CC, Verweij KJH, van der Most PJ, Mbarek H, Bernard M, van Eijk KR, Lind PA, Liu MZ, Maciejewski DF, Palviainen T, Sánchez-Mora C, Sherva R, Taylor M, Walters RK, Abdellaoui A, ... ... Kahn RS, et al. GENOME-WIDE ASSOCIATION META-ANALYSIS OF AGE AT FIRST CANNABIS USE. Addiction (Abingdon, England). PMID 30003630 DOI: 10.1111/add.14368  0.6
2018 van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, ... ... Kahn RS, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biological Psychiatry. PMID 29960671 DOI: 10.1016/j.biopsych.2018.04.023  0.68
2018 de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W. Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls. Psychiatry Research. 266: 147-151. PMID 29864614 DOI: 10.1016/j.psychres.2018.05.009  0.68
2018 Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Translational Psychiatry. 8: 96. PMID 29743478 DOI: 10.1038/s41398-018-0107-9  0.6
2018 Schijven D, Kofink D, Tragante V, Verkerke M, Pulit SL, Kahn RS, Veldink JH, Vinkers CH, Boks MP, Luykx JJ. Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling. Schizophrenia Research. PMID 29653892 DOI: 10.1016/j.schres.2018.03.032  0.6
2018 Ferguson B, Petridou N, Fracasso A, van den Heuvel MP, Brouwer RM, Hulshoff Pol HE, Kahn RS, Mandl RCW. Detailed T1-Weighted Profiles from the Human Cortex Measured in Vivo at 3 Tesla MRI. Neuroinformatics. PMID 29352389 DOI: 10.1007/s12021-018-9356-2  0.56
2017 Leendertse P, Myin-Germeys I, Lataster T, Simons CJP, Oorschot M, Lardinois M, Schneider M, van Os J, Reininghaus U, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, ... ... Kahn RS, et al. Subjective quality of life in psychosis: Evidence for an association with real world functioning? Psychiatry Research. 261: 116-123. PMID 29291477 DOI: 10.1016/j.psychres.2017.11.074  0.68
2017 Nuninga JO, Bohlken MM, Koops S, Fiksinski AM, Mandl RCW, Breetvelt EJ, Duijff SN, Kahn RS, Sommer IEC, Vorstman JAS. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline. Psychological Medicine. 1-9. PMID 29143717 DOI: 10.1017/S0033291717003142  0.6
2017 Snijders G, Titulaer MJ, Bergink V, Bastiaansen AE, Schreurs MWJ, Ophoff RA, Boks MP, Kahn RS, de Witte LD. No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder. Psychiatry Research. 259: 460-462. PMID 29136601 DOI: 10.1016/j.psychres.2017.10.043  0.6
2017 Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, ... Kahn RS, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/j.schres.2017.09.024  0.68
2017 Marsman A, Mandl RCW, Klomp DWJ, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA. Frontiers in Psychiatry. 8: 154. PMID 28966597 DOI: 10.3389/fpsyt.2017.00154  0.68
2017 Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, ... ... Kahn RS, et al. An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility. Psychiatry Research. PMID 28851542 DOI: 10.1016/j.psychres.2017.08.017  0.68
2017 Collin G, Scholtens LH, Kahn RS, Hillegers MHJ, van den Heuvel MP. Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients. Biological Psychiatry. PMID 28734460 DOI: 10.1016/j.biopsych.2017.06.013  0.68
2017 Keunen K, Benders MJ, Leemans A, Fieret-Van Stam PC, Scholtens LH, Viergever MA, Kahn RS, Groenendaal F, de Vries LS, van den Heuvel MP. White matter maturation in the neonatal brain is predictive of school age cognitive capacities in children born very preterm. Developmental Medicine and Child Neurology. PMID 28675542 DOI: 10.1111/dmcn.13487  0.56
2017 Wei Y, Collin G, Mandl RCW, Cahn W, Keunen K, Schmidt R, Kahn RS, van den Heuvel MP. Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia. Schizophrenia Research. PMID 28601503 DOI: 10.1016/j.schres.2017.05.029  0.68
2017 Mansueto G, van Nierop M, Schruers K, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, et al. The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders. Schizophrenia Research. PMID 28416093 DOI: 10.1016/j.schres.2017.04.003  0.68
2017 Verkooijen S, Stevelink R, Abramovic L, Vinkers CH, Ophoff RA, Kahn RS, Boks MP, van Haren NE. The association of sleep and physical activity with integrity of white matter microstructure in bipolar disorder patients and healthy controls. Psychiatry Research. 262: 71-80. PMID 28236715 DOI: 10.1016/j.pscychresns.2017.01.013  0.6
2017 Chang X, Collin G, Xi Y, Cui L, Scholtens LH, Sommer IE, Wang H, Yin H, Kahn RS, van den Heuvel MP. Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report. Schizophrenia Research. PMID 28130005 DOI: 10.1016/j.schres.2017.01.024  0.56
2017 Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, ... ... Kahn RS, et al. Novel genetic loci associated with hippocampal volume. Nature Communications. 8: 13624. PMID 28098162 DOI: 10.1038/ncomms13624  0.6
2016 Prikken M, van der Weiden A, Renes RA, Koevoets MG, Heering HD, Kahn RS, Aarts H, van Haren NE. Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk. Psychiatry Research. 250: 270-276. PMID 28189096 DOI: 10.1016/j.psychres.2016.10.077  0.52
2016 Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 77: 25-36. PMID 28012291 DOI: 10.1016/j.psyneuen.2016.11.036  0.6
2016 Verkooijen S, van Bergen AH, Knapen SE, Vreeker A, Abramovic L, Pagani L, Jung Y, Riemersma-van der Lek R, Schoevers RA, Takahashi JS, Kahn RS, Boks MP, Ophoff RA. An actigraphy study investigating sleep in bipolar I patients, unaffected siblings and controls. Journal of Affective Disorders. 208: 248-254. PMID 27792970 DOI: 10.1016/j.jad.2016.08.076  0.6
2016 Romme IA, de Reus MA, Ophoff RA, Kahn RS, van den Heuvel MP. Connectome Disconnectivity and Cortical Gene Expression in Patients With Schizophrenia. Biological Psychiatry. PMID 27720199 DOI: 10.1016/j.biopsych.2016.07.012  0.56
2016 Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, ... ... Kahn RS, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nature Neuroscience. PMID 27694991 DOI: 10.1038/nn.4398  0.76
2016 Abramovic L, Boks MP, Vreeker A, Bouter DC, Kruiper C, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NE. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27665062 DOI: 10.1016/j.euroneuro.2016.09.371  0.6
2016 Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, Kahn RS, Vermetten E, Vinkers CH. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 73: 263-270. PMID 27566489 DOI: 10.1016/j.psyneuen.2016.08.014  0.68
2016 de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M. Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27440007 DOI: 10.1038/npp.2016.130  0.92
2016 Bossong MG, Kahn RS. The Salience of Reward. Jama Psychiatry. PMID 27384314 DOI: 10.1001/jamapsychiatry.2016.1134  0.92
2016 Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Biological Psychiatry. PMID 27316853 DOI: 10.1016/j.biopsych.2016.04.007  0.68
2016 Buoli M, Kahn RS, Serati M, Altamura AC, Cahn W. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia. Human Psychopharmacology. PMID 27297936 DOI: 10.1002/hup.2542  0.68
2016 Schür RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joëls M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Human Brain Mapping. PMID 27145016 DOI: 10.1002/hbm.23244  0.6
2016 Bohlken MM, Brouwer RM, Mandl RC, Kahn RS, Hulshoff Pol HE. Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure. Schizophrenia Bulletin. PMID 27056715 DOI: 10.1093/schbul/sbw034  0.64
2016 Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, Meeus W, Branje S, Heim CM, Nemeroff CB, Mill J, Schalkwyk LC, Creyghton MP, Kahn RS, Joëls M, Binder EB, et al. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nature Communications. 7: 10967. PMID 26997371 DOI: 10.1038/ncomms10967  0.6
2016 Heering HD, Goedhart S, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D. Disturbed Experience of Self: Psychometric Analysis of the Self-Experience Lifetime Frequency Scale (SELF). Psychopathology. PMID 26992167 DOI: 10.1159/000441952  0.68
2016 Schnack HG, van Haren NE, Nieuwenhuis M, Hulshoff Pol HE, Cahn W, Kahn RS. Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study. The American Journal of Psychiatry. appiajp201515070922. PMID 26917166 DOI: 10.1176/appi.ajp.2015.15070922  0.68
2016 Kleerekooper I, van Rooij SJ, van den Wildenberg WP, de Leeuw M, Kahn RS, Vink M. The effect of aging on fronto-striatal reactive and proactive inhibitory control. Neuroimage. PMID 26899783 DOI: 10.1016/j.neuroimage.2016.02.031  0.92
2016 Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Kahn RS, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/mp.2015.227  0.6
2016 Kennis M, Van Rooij SJH, Van Den Heuvel MP, Kahn RS, Geuze E. Functional network topology associated with posttraumatic stress disorder in veterans Neuroimage: Clinical. 10: 302-309. DOI: 10.1016/j.nicl.2015.12.008  0.92
2015 de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. Npj Schizophrenia. 1: 15001. PMID 27336028 DOI: 10.1038/npjschz.2015.1  0.92
2015 Renes RA, Vink M, van der Weiden A, Prikken M, Koevoets MG, Kahn RS, Aarts H, van Haren NE. Impaired frontal processing during agency inferences in schizophrenia. Psychiatry Research. PMID 26776080 DOI: 10.1016/j.pscychresns.2015.12.006  0.92
2015 Maat A, van Haren NE, Bartholomeusz CF, Kahn RS, Cahn W. Emotion recognition and theory of mind are related to gray matter volume of the prefrontal cortex in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26711688 DOI: 10.1016/j.euroneuro.2015.12.013  1
2015 Volavka J, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Czobor P. Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. European Psychiatry : the Journal of the Association of European Psychiatrists. 31: 13-19. PMID 26657597 DOI: 10.1016/j.eurpsy.2015.10.003  0.92
2015 van den Heuvel MP, Scholtens LH, de Reus MA, Kahn RS. Associated Microscale Spine Density and Macroscale Connectivity Disruptions in Schizophrenia. Biological Psychiatry. PMID 26632269 DOI: 10.1016/j.biopsych.2015.10.005  1
2015 Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophrenia Research. PMID 26631365 DOI: 10.1016/j.schres.2015.11.018  1
2015 Bohlken MM, Brouwer RM, Mandl RC, Van den Heuvel MP, Hedman AM, De Hert M, Cahn W, Kahn RS, Hulshoff Pol HE. Structural Brain Connectivity as a Genetic Marker for Schizophrenia. Jama Psychiatry. 1-9. PMID 26606729 DOI: 10.1001/jamapsychiatry.2015.1925  0.68
2015 Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophrenia Bulletin. PMID 26598739 DOI: 10.1093/schbul/sbv166  0.92
2015 Stringer S, Denys D, Kahn RS, Derks EM. What Cure Models Can Teach us About Genome-Wide Survival Analysis. Behavior Genetics. PMID 26552795 DOI: 10.1007/s10519-015-9764-0  0.88
2015 Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R, Hillegers MH, Boomsma DI, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481908 DOI: 10.1016/j.euroneuro.2015.09.023  0.68
2015 Collin G, van den Heuvel MP, Abramovic L, Vreeker A, de Reus MA, van Haren NE, Boks MP, Ophoff RA, Kahn RS. Brain network analysis reveals affected connectome structure in bipolar I disorder. Human Brain Mapping. PMID 26454006 DOI: 10.1002/hbm.23017  1
2015 van Haren NE, Schnack HG, Koevoets MG, Cahn W, Hulshoff Pol HE, Kahn RS. Trajectories of subcortical volume change in schizophrenia: A 5-year follow-up. Schizophrenia Research. PMID 26439952 DOI: 10.1016/j.schres.2015.09.027  1
2015 Bohlken MM, Brouwer RM, Mandl RC, Hedman AM, van den Heuvel MP, van Haren NE, Kahn RS, Hulshoff Pol HE. Topology of genetic associations between regional gray matter volume and intellectual ability: Evidence for a high capacity network. Neuroimage. 124: 1044-1053. PMID 26424180 DOI: 10.1016/j.neuroimage.2015.09.046  0.56
2015 van Mierlo HC, Titulaer MJ, Kromkamp M, van de Kraats R, van Veelen NM, Palmen SJ, Kahn RS, de Witte LD. Early recognition of anti-N-methyl-D-aspartate receptor encephalitis in psychiatric patients. Acta Psychiatrica Scandinavica. 132: 312-3. PMID 26371800 DOI: 10.1111/acps.12471  1
2015 Koenis MM, Brouwer RM, van den Heuvel MP, Mandl RC, van Soelen IL, Kahn RS, Boomsma DI, Hulshoff Pol HE. Development of the brain's structural network efficiency in early adolescence: A longitudinal DTI twin study. Human Brain Mapping. PMID 26368846 DOI: 10.1002/hbm.22988  1
2015 Kahn RS, Giannopoulou A. The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia. Expert Review of Neurotherapeutics. 15: 969-81. PMID 26289486 DOI: 10.1586/14737175.2015.1070670  1
2015 Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Kahn RS, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/ije/dyv136  1
2015 Heering HD, Koevoets GJ, Koenders L, Machielsen MW, Meijer CJ, Kubota M, de Nijs J, Cahn W, Hulshoff Pol HE, de Haan L, Kahn RS, van Haren NE. Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? Frontiers in Psychiatry. 6: 107. PMID 26283974 DOI: 10.3389/fpsyt.2015.00107  0.68
2015 Stringer S, Cerrone KC, van den Brink W, van den Berg JF, Denys D, Kahn RS, Derks EM. A guide on gene prioritization in studies of psychiatric disorders. International Journal of Methods in Psychiatric Research. PMID 26230968 DOI: 10.1002/mpr.1482  1
2015 Emsley R, Asmal L, Chiliza B, du Plessis S, Carr J, Kidd M, Malhotra AK, Vink M, Kahn RS. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia. Psychiatry Research. PMID 26184461 DOI: 10.1016/j.pscychresns.2015.06.014  1
2015 Loohuis LM, Vorstman JA, Ori AP, Staats KA, Wang T, Richards AL, Leonenko G, Walters JT, DeYoung J, Cantor RM, Ophoff RA. Genome-wide burden of deleterious coding variants increased in schizophrenia. Nature Communications. 6: 7501. PMID 26158538 DOI: 10.1038/ncomms8501  1
2015 Rösler L, Rolfs M, Van der Stigchel S, Neggers SF, Cahn W, Kahn RS, Thakkar KN. Failure to use corollary discharge to remap visual target locations is associated with psychotic symptom severity in schizophrenia. Journal of Neurophysiology. jn.00155.2015. PMID 26108951 DOI: 10.1152/jn.00155.2015  1
2015 Kubota M, van Haren NE, Haijma SV, Schnack HG, Cahn W, Hulshoff Pol HE, Kahn RS. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia. Jama Psychiatry. PMID 26083394 DOI: 10.1001/jamapsychiatry.2015.0712  1
2015 Somers M, Ophoff RA, Aukes MF, Cantor RM, Boks MP, Dauwan M, de Visser KL, Kahn RS, Sommer IE. Linkage analysis in a Dutch population isolate shows no major gene for left-handedness or atypical language lateralization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8730-6. PMID 26063907 DOI: 10.1523/JNEUROSCI.3287-14.2015  1
2015 van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26033243 DOI: 10.1038/mp.2015.63  1
2015 Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1158-66. PMID 26004980 DOI: 10.1016/j.euroneuro.2015.04.003  1
2015 de Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P. Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies. Jama Psychiatry. 72: 731-3. PMID 25970159 DOI: 10.1001/jamapsychiatry.2015.0526  1
2015 van Nierop M, Bak M, de Graaf R, Ten Have M, van Dorsselaer S, van Winkel R. The functional and clinical relevance of childhood trauma-related admixture of affective, anxious and psychosis symptoms. Acta Psychiatrica Scandinavica. PMID 25961128 DOI: 10.1111/acps.12437  0.68
2015 Vreeker A, van Bergen AH, Kahn RS. Cognitive enhancing agents in schizophrenia and bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 969-1002. PMID 25957798 DOI: 10.1016/j.euroneuro.2015.04.014  1
2015 van Rooij SJ, Kennis M, Sjouwerman R, van den Heuvel MP, Kahn RS, Geuze E. Smaller hippocampal volume as a vulnerability factor for the persistence of post-traumatic stress disorder. Psychological Medicine. 45: 2737-46. PMID 25936409 DOI: 10.1017/S0033291715000707  1
2015 Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 808-16. PMID 25907250 DOI: 10.1016/j.euroneuro.2015.02.012  1
2015 Somers M, Aukes MF, Ophoff RA, Boks MP, Fleer W, de Visser KC, Kahn RS, Sommer IE. On the relationship between degree of hand-preference and degree of language lateralization. Brain and Language. 144: 10-5. PMID 25880901 DOI: 10.1016/j.bandl.2015.03.006  1
2015 Arango C, Kapur S, Kahn RS. Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia. Schizophrenia Bulletin. 41: 546-8. PMID 25864201 DOI: 10.1093/schbul/sbv026  1
2015 Zandi T, Havenaar JM, Laan W, Kahn RS, Brink WV. Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral. Transcultural Psychiatry. PMID 25851336 DOI: 10.1177/1363461515577288  1
2015 Renes RA, van der Weiden A, Prikken M, Kahn RS, Aarts H, van Haren NE. Abnormalities in the experience of self-agency in schizophrenia: A replication study. Schizophrenia Research. 164: 210-3. PMID 25843918 DOI: 10.1016/j.schres.2015.03.015  1
2015 Kennis M, van Rooij SJ, Tromp DP, Fox AS, Rademaker AR, Kahn RS, Kalin NH, Geuze E. Treatment Outcome-Related White Matter Differences in Veterans with Posttraumatic Stress Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25837284 DOI: 10.1038/npp.2015.94  1
2015 Svatkova A, Mandl RC, Scheewe TW, Cahn W, Kahn RS, Hulshoff Pol HE. Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy Controls. Schizophrenia Bulletin. 41: 869-78. PMID 25829377 DOI: 10.1093/schbul/sbv033  1
2015 Bruining H, Matsui A, Oguro-Ando A, Kahn RS, Van't Spijker HM, Akkermans G, Stiedl O, van Engeland H, Koopmans B, van Lith HA, Oppelaar H, Tieland L, Nonkes LJ, Yagi T, Kaneko R, et al. Genetic Mapping in Mice Reveals the Involvement of Pcdh9 in Long-Term Social and Object Recognition and Sensorimotor Development. Biological Psychiatry. PMID 25802080 DOI: 10.1016/j.biopsych.2015.01.017  1
2015 Bossong MG, Mehta MA, van Berckel BN, Howes OD, Kahn RS, Stokes PR. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. 232: 2723-9. PMID 25801289 DOI: 10.1007/s00213-015-3915-0  1
2015 Sommer IE, Kahn RS. The Magic of Movement; the Potential of Exercise to Improve Cognition. Schizophrenia Bulletin. 41: 776-8. PMID 25800250 DOI: 10.1093/schbul/sbv031  1
2015 Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophrenia Bulletin. 41: 574-83. PMID 25800248 DOI: 10.1093/schbul/sbv024  1
2015 Leucht S, Winter-van Rossum I, Heres S, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leweke FM, Lewis S, McGuire P, Meyer-Lindenberg A, Rujescu D, Kapur S, Kahn RS, Sommer IE. The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics. Schizophrenia Bulletin. 41: 549-58. PMID 25786408 DOI: 10.1093/schbul/sbv019  1
2015 Fond G, d'Albis MA, Jamain S, Tamouza R, Arango C, Fleischhacker WW, Glenthøj B, Leweke M, Lewis S, McGuire P, Meyer-Lindenberg A, Sommer IE, Winter-van Rossum I, Kapur S, Kahn RS, et al. The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophrenia Bulletin. 41: 559-73. PMID 25759473 DOI: 10.1093/schbul/sbv002  1
2015 Drake RJ, Nordentoft M, Haddock G, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leucht S, Leweke M, McGuire P, Meyer-Lindenberg A, Rujescu D, Sommer IE, Kahn RS, Lewis SW. Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention. Schizophrenia Bulletin. 41: 584-96. PMID 25750247 DOI: 10.1093/schbul/sbv015  1
2015 Kochunov P, Jahanshad N, Marcus D, Winkler A, Sprooten E, Nichols TE, Wright SN, Hong LE, Patel B, Behrens T, Jbabdi S, Andersson J, Lenglet C, Yacoub E, Moeller S, ... ... Kahn R, et al. Heritability of fractional anisotropy in human white matter: a comparison of Human Connectome Project and ENIGMA-DTI data. Neuroimage. 111: 300-11. PMID 25747917 DOI: 10.1016/j.neuroimage.2015.02.050  1
2015 Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, ... ... Kahn RS, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/jamapsychiatry.2014.2671  1
2015 Vink M, Kleerekooper I, van den Wildenberg WP, Kahn RS. Impact of aging on frontostriatal reward processing. Human Brain Mapping. 36: 2305-17. PMID 25704624 DOI: 10.1002/hbm.22771  1
2015 Vinkers CH, Joëls M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, Boks MP. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 54: 90-102. PMID 25686805 DOI: 10.1016/j.psyneuen.2015.01.018  1
2015 Luykx JJ, Bakker SC, Visser WF, Verhoeven-Duif N, Buizer-Voskamp JE, den Heijer JM, Boks MP, Sul JH, Eskin E, Ori AP, Cantor RM, Vorstman J, Strengman E, DeYoung J, Kappen TH, ... ... Kahn RS, et al. Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma. Molecular Psychiatry. PMID 25666758 DOI: 10.1038/mp.2014.190  1
2015 Schirmbeck F, Boyette LL, van der Valk R, Meijer C, Dingemans P, Van R, de Haan L, Kahn RS, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, et al. Relevance of Five-Factor Model personality traits for obsessive-compulsive symptoms in patients with psychotic disorders and their un-affected siblings. Psychiatry Research. 225: 464-70. PMID 25613659 DOI: 10.1016/j.psychres.2014.11.066  1
2015 Somers M, Shields LS, Boks MP, Kahn RS, Sommer IE. Cognitive benefits of right-handedness: a meta-analysis. Neuroscience and Biobehavioral Reviews. 51: 48-63. PMID 25592981 DOI: 10.1016/j.neubiorev.2015.01.003  0.6
2015 Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/j.schres.2014.11.027  1
2015 Mandl RC, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, Hulshoff Pol HE. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophrenia Research. 161: 126-32. PMID 25454797 DOI: 10.1016/j.schres.2014.09.046  1
2015 Houtepen LC, Boks MP, Kahn RS, Joëls M, Vinkers CH. Antipsychotic use is associated with a blunted cortisol stress response: a study in euthymic bipolar disorder patients and their unaffected siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 77-84. PMID 25453485 DOI: 10.1016/j.euroneuro.2014.10.005  1
2015 van Eijk KR, de Jong S, Strengman E, Buizer-Voskamp JE, Kahn RS, Boks MP, Horvath S, Ophoff RA. Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood. European Journal of Human Genetics : Ejhg. 23: 1106-10. PMID 25424713 DOI: 10.1038/ejhg.2014.245  1
2015 de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 41: 94-103. PMID 25368371 DOI: 10.1093/schbul/sbu153  1
2015 Sommer IE, Kahn RS. The contribution of neuroimaging to understanding schizophrenia; past, present, and future. Schizophrenia Bulletin. 41: 1-3. PMID 25347988 DOI: 10.1093/schbul/sbu141  1
2015 Arango C, Kahn RS. More treatment for those most in need? A foregone conclusion? Schizophrenia Bulletin. 41: 26-7. PMID 25344948 DOI: 10.1093/schbul/sbu149  1
2015 van Nierop M, Viechtbauer W, Gunther N, van Zelst C, de Graaf R, Ten Have M, van Dorsselaer S, Bak M, van Winkel R. Childhood trauma is associated with a specific admixture of affective, anxiety, and psychosis symptoms cutting across traditional diagnostic boundaries. Psychological Medicine. 45: 1277-88. PMID 25273550 DOI: 10.1017/S0033291714002372  1
2015 Kennis M, Rademaker AR, van Rooij SJ, Kahn RS, Geuze E. Resting state functional connectivity of the anterior cingulate cortex in veterans with and without post-traumatic stress disorder. Human Brain Mapping. 36: 99-109. PMID 25137414 DOI: 10.1002/hbm.22615  1
2015 Pos K, Bartels-Velthuis AA, Simons CJP, Korver-Nieberg N, Meijer CJ, De Haan L, Bruggeman R, Cahn W, Kahn RS, Myin-Germeys I, Van Os J, Wiersma D. Theory of Mind and attachment styles in people with psychotic disorders, their siblings, and controls Australian and New Zealand Journal of Psychiatry. 49: 171-180. PMID 25122450 DOI: 10.1177/0004867414546386  1
2015 Bootsman F, Brouwer RM, Schnack HG, van Baal GC, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychological Medicine. 45: 193-204. PMID 25065711 DOI: 10.1017/S0033291714001251  1
2015 van Dam DS, van Nierop M, Viechtbauer W, Velthorst E, van Winkel R, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D. Childhood abuse and neglect in relation to the presence and persistence of psychotic and depressive symptomatology. Psychological Medicine. 45: 1363-77. PMID 25065372 DOI: 10.1017/S0033291714001561  1
2015 Kahn RS, Sommer IE. The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry. 20: 84-97. PMID 25048005 DOI: 10.1038/mp.2014.66  1
2015 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD. Psychological Medicine. 45: 575-87. PMID 25036523 DOI: 10.1017/S0033291714001706  1
2015 Schnack HG, van Haren NE, Brouwer RM, Evans A, Durston S, Boomsma DI, Kahn RS, Hulshoff Pol HE. Changes in thickness and surface area of the human cortex and their relationship with intelligence. Cerebral Cortex (New York, N.Y. : 1991). 25: 1608-17. PMID 24408955 DOI: 10.1093/cercor/bht357  1
2015 Heering HD, Koevoets GJC, Koenders L, Machielsen MWJ, Meijer CJ, Kubota M, de Nijs J, Cahn W, Hulshoff Pol HE, de Haan L, Kahn RS, van Haren NEM. Structural MRI differences between patients with and without first rank symptoms: A delusion? Frontiers in Psychiatry. 6. DOI: 10.3389/fpsyt.2015.00107  1
2015 Van Der Leeuw C, Peeters S, Domen P, Van Kroonenburgh M, Van Os J, Marcelis M, Bruggeman R, Cahn W, De L, Kahn RS, Meijer C, Myin-Germeys I, Wiersma D. Bone mineral density as a marker of cumulative estrogen exposure in psychotic disorder: A 3 year follow-up study Plos One. 10. DOI: 10.1371/journal.pone.0136320  1
2015 Swets M, Van Dael F, Roza S, Schoevers R, Myin-Germeys I, De Haan L, Bruggeman R, Cahn W, Kahn RS, Meijer CJ, Van Os J, Wiersma D. Evidence for a shared etiological mechanism of psychotic symptoms and obsessive-compulsive symptoms in patients with psychotic disorders and their siblings Plos One. 10. DOI: 10.1371/journal.pone.0125103  1
2015 Van Zelst C, Van Nierop M, Van Dam DS, Bartels-Velthuis AA, Delespaul P, Bruggeman R, Cahn W, De Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, Van Os J, Wiersma D. Associations between stereotype awareness, childhood trauma and psychopathology: A study in people with psychosis, their siblings and controls Plos One. 10. DOI: 10.1371/journal.pone.0117386  1
2015 Smeets F, Lataster T, Viechtbauer W, Delespaul P, Bruggeman R, Cahn W, De Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, Van Os J, Wiersma D. Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation Schizophrenia Bulletin. 41: 687-697. DOI: 10.1093/schbul/sbu122  1
2015 van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium Molecular Psychiatry. DOI: 10.1038/mp.2015.118  1
2015 van Mierlo HC, van Coevorden-Hameete MH, Munting LP, de Graaff E, de Witte L, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D. No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia European Neuropsychopharmacology. 25: 2326-2332. DOI: 10.1016/j.euroneuro.2015.09.017  1
2015 De Leeuw M, Kahn RS. Towards an fMRI prediction test for schizophrenia? | Op weg naar een fMRI-predictietest voor schizofrenie? Tijdschrift Voor Psychiatrie. 57: 459.  1
2014 Sommer IE, Kahn RS. Psychosis susceptibility syndrome: an alternative name for schizophrenia. The Lancet. Psychiatry. 1: 111. PMID 26360567 DOI: 10.1016/S2215-0366(14)70288-3  1
2014 De Nijs J, Zoun KR, Bruggeman R, Cahn W, Magnus R, De Haan L, Kahn RS, Meijer C, Myin-Germeys I, Van Os J, Wiersma D. The association between cognitive deficits and different outcomes of schizophrenia | Deficyty poznawcze a efekty schizofrenii Psychiatria Polska. 48: 1087-1104. PMID 25717480  1
2014 Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1885-95. PMID 25451699 DOI: 10.1016/j.euroneuro.2014.09.010  1
2014 Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 25450228 DOI: 10.1038/mp.2014.152  1
2014 Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage. Clinical. 6: 398-407. PMID 25379453 DOI: 10.1016/j.nicl.2014.10.005  1
2014 Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Boos HB, Schnack HG, Cahn W, Hoogman M, Zwiers MP, Fernandez G, Franke B, Hulshoff Pol HE, Kahn RS. Association study of fibroblast growth factor genes and brain volumes in schizophrenic patients and healthy controls. Psychiatric Genetics. 24: 283-4. PMID 25360608 DOI: 10.1097/YPG.0000000000000057  1
2014 Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophrenia Research. 159: 347-52. PMID 25266548 DOI: 10.1016/j.schres.2014.09.004  1
2014 Meijer JH, van Harten P, Meijer CJ, Koeter MW, Bruggeman R, Cahn W, Kahn RS, de Haan L. Association between olfactory identification and parkinsonism in patients with non-affective psychosis. Early Intervention in Psychiatry. PMID 25234230 DOI: 10.1111/eip.12183  0.68
2014 Tempelaar WM, Otjes CP, Bun CJ, Plevier CM, van Gastel WA, MacCabe JH, Kahn RS, Boks MP. Delayed school progression and mental health problems in adolescence: a population-based study in 10,803 adolescents. Bmc Psychiatry. 14: 244. PMID 25217816 DOI: 10.1186/s12888-014-0244-5  1
2014 de Reus MA, Saenger VM, Kahn RS, van den Heuvel MP. An edge-centric perspective on the human connectome: link communities in the brain. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369. PMID 25180305 DOI: 10.1098/rstb.2013.0527  1
2014 Lako IM, Wigman JTW, Klaassen RMC, Slooff CJ, Taxis K, Bartels-Velthuis AA, Bruggeman R, Wiersma D, Cahn W, Kahn RS, de Haan L, Meijer CJ, Myin-Germeys I, van Os J. Psychometric properties of the self-report version of the Quick inventory of depressive symptoms (QIDS-SR16) questionnaire in patients with schizophrenia Bmc Psychiatry. 14. PMID 25178310 DOI: 10.1186/s12888-014-0247-2  1
2014 Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, Fleischhacker WW, Kahn RS, Peuskens J. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1500-5. PMID 25085534 DOI: 10.1016/j.euroneuro.2014.07.001  1
2014 Apeldoorn SY, Sterk B, van den Heuvel ER, Schoevers RA, Islam MA, Bruggeman R, Cahn W, deHaan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D. Factors contributing to the duration of untreated psychosis. Schizophrenia Research. 158: 76-81. PMID 25043913 DOI: 10.1016/j.schres.2014.07.002  1
2014 Plongthongkum N, van Eijk KR, de Jong S, Wang T, Sul JH, Boks MP, Kahn RS, Fung HL, Ophoff RA, Zhang K. Characterization of genome-methylome interactions in 22 nuclear pedigrees. Plos One. 9: e99313. PMID 25019935 DOI: 10.1371/journal.pone.0099313  1
2014 Quee PJ, Meijer JH, Islam MA, Aleman A, Alizadeh BZ, Meijer CJ, van den Heuvel ER. Premorbid adjustment profiles in psychosis and the role of familial factors. Journal of Abnormal Psychology. 123: 578-87. PMID 25000154 DOI: 10.1037/a0037189  1
2014 Thakkar KN, van den Heiligenberg FM, Kahn RS, Neggers SF. Frontal-subcortical circuits involved in reactive control and monitoring of gaze. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8918-29. PMID 24966390 DOI: 10.1523/JNEUROSCI.0732-14.2014  1
2014 van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain : a Journal of Neurology. 137: 2664-9. PMID 24951640 DOI: 10.1093/brain/awu167  1
2014 van Gastel WA, Vreeker A, Schubart CD, MacCabe JH, Kahn RS, Boks MP. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences. Schizophrenia Research. 157: 266-70. PMID 24930951 DOI: 10.1016/j.schres.2014.04.023  1
2014 Mandl RC, Schnack HG, Zwiers MP, Kahn RS, Hulshoff Pol HE. Do we measure gray matter activation with functional diffusion tensor imaging? Frontiers in Neuroscience. 8: 126. PMID 24904267 DOI: 10.3389/fnins.2014.00126  1
2014 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Impaired right inferior frontal gyrus response to contextual cues in male veterans with PTSD during response inhibition. Journal of Psychiatry & Neuroscience : Jpn. 39: 330-8. PMID 24886789 DOI: 10.1503/jpn.130223  1
2014 Bohlken MM, Mandl RC, Brouwer RM, van den Heuvel MP, Hedman AM, Kahn RS, Hulshoff Pol HE. Heritability of structural brain network topology: a DTI study of 156 twins. Human Brain Mapping. 35: 5295-305. PMID 24845163 DOI: 10.1002/hbm.22550  1
2014 van den Heuvel MP, Kersbergen KJ, de Reus MA, Keunen K, Kahn RS, Groenendaal F, de Vries LS, Benders MJ. The Neonatal Connectome During Preterm Brain Development. Cerebral Cortex (New York, N.Y. : 1991). PMID 24833018 DOI: 10.1093/cercor/bhu095  0.56
2014 Brouwer RM, Hedman AM, van Haren NE, Schnack HG, Brans RG, Smit DJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of brain volume change and its relation to intelligence. Neuroimage. 100: 676-83. PMID 24816534 DOI: 10.1016/j.neuroimage.2014.04.072  1
2014 Boyette LL, Van Dam D, Meijer C, Velthorst E, Cahn W, De Haan L, Kahn R, Van Os J, Wiersma D, Bruggeman R, Myin-Germeys I. Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events Schizophrenia Bulletin. 40: 1356-1365. PMID 24771304 DOI: 10.1093/schbul/sbu057  1
2014 Vinkers CH, Joëls M, Milaneschi Y, Kahn RS, Penninx BW, Boks MP. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depression and Anxiety. 31: 737-45. PMID 24753162 DOI: 10.1002/da.22262  1
2014 van Gastel WA, MacCabe JH, Schubart CD, van Otterdijk E, Kahn RS, Boks MP. Cannabis use is a better indicator of poor mental health in women than in men: a cross-sectional study in young adults from the general population. Community Mental Health Journal. 50: 823-30. PMID 24728845 DOI: 10.1007/s10597-014-9699-6  1
2014 Ziermans T, de Wit S, Schothorst P, Sprong M, van Engeland H, Kahn R, Durston S. Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up. Plos One. 9: e93994. PMID 24705808 DOI: 10.1371/journal.pone.0093994  1
2014 Kochunov P, Jahanshad N, Sprooten E, Nichols TE, Mandl RC, Almasy L, Booth T, Brouwer RM, Curran JE, de Zubicaray GI, Dimitrova R, Duggirala R, Fox PT, Hong LE, Landman BA, ... ... Kahn RS, et al. Multi-site study of additive genetic effects on fractional anisotropy of cerebral white matter: Comparing meta and megaanalytical approaches for data pooling. Neuroimage. 95: 136-50. PMID 24657781 DOI: 10.1016/j.neuroimage.2014.03.033  1
2014 de Wit S, Schothorst PF, Oranje B, Ziermans TB, Durston S, Kahn RS. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 865-73. PMID 24636460 DOI: 10.1016/j.euroneuro.2014.02.008  1
2014 de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/j.schres.2014.02.005  1
2014 Vink M, Zandbelt BB, Gladwin T, Hillegers M, Hoogendam JM, van den Wildenberg WP, Du Plessis S, Kahn RS. Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood. Human Brain Mapping. 35: 4415-27. PMID 24532023 DOI: 10.1002/hbm.22483  1
2014 Vink M, Derks JM, Hoogendam JM, Hillegers M, Kahn RS. Functional differences in emotion processing during adolescence and early adulthood. Neuroimage. 91: 70-6. PMID 24468408 DOI: 10.1016/j.neuroimage.2014.01.035  1
2014 Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 575-84. PMID 24418213 DOI: 10.1016/j.euroneuro.2013.12.009  1
2014 De Jong S, Neeleman M, Luykx JJ, ten Berg MJ, Strengman E, Den Breeijen HH, Stijvers LC, Buizer-Voskamp JE, Bakker SC, Kahn RS, Horvath S, Van Solinge WW, Ophoff RA. Seasonal changes in gene expression represent cell-type composition in whole blood. Human Molecular Genetics. 23: 2721-8. PMID 24399446 DOI: 10.1093/hmg/ddt665  1
2014 Brouwer RM, van Soelen IL, Swagerman SC, Schnack HG, Ehli EA, Kahn RS, Hulshoff Pol HE, Boomsma DI. Genetic associations between intelligence and cortical thickness emerge at the start of puberty. Human Brain Mapping. 35: 3760-73. PMID 24382822 DOI: 10.1002/hbm.22435  1
2014 Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 51-64. PMID 24309088 DOI: 10.1016/j.euroneuro.2013.11.002  1
2014 Collin G, Kahn RS, de Reus MA, Cahn W, van den Heuvel MP. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 40: 438-48. PMID 24298172 DOI: 10.1093/schbul/sbt162  1
2014 Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophrenia Bulletin. 40: 181-91. PMID 24106335 DOI: 10.1093/schbul/sbt139  1
2014 Bohlken MM, Brouwer RM, Mandl RC, van Haren NE, Brans RG, van Baal GC, de Geus EJ, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genes contributing to subcortical volumes and intellectual ability implicate the thalamus. Human Brain Mapping. 35: 2632-42. PMID 24038793 DOI: 10.1002/hbm.22356  1
2014 Schnack HG, Nieuwenhuis M, van Haren NE, Abramovic L, Scheewe TW, Brouwer RM, Hulshoff Pol HE, Kahn RS. Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage. 84: 299-306. PMID 24004694 DOI: 10.1016/j.neuroimage.2013.08.053  1
2014 Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Kahn RS, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/j.biopsych.2013.03.033  0.68
2014 Quee PJ, Alizadeh BZ, Aleman A, van den Heuvel ER. Cognitive subtypes in non-affected siblings of schizophrenia patients: characteristics and profile congruency with affected family members. Psychological Medicine. 44: 395-405. PMID 23659373 DOI: 10.1017/S0033291713000809  1
2014 Lataster T, Verweij K, Viechtbauer W, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Effect of illness expression and liability on familial associations of clinical and subclinical psychosis phenotypes Acta Psychiatrica Scandinavica. 129: 44-53. PMID 23465170 DOI: 10.1111/acps.12102  1
2014 Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, ... ... Kahn RS, et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Molecular Psychiatry. 19: 228-34. PMID 23319000 DOI: 10.1038/mp.2012.183  1
2014 Boyette LL, Korver-Nieberg N, Meijer C, De Haan L, Kahn RS, Van Os J, Wiersma D, Bruggeman R, Cahn W, Myin-Germeys I. Quality of life in patients with psychotic disorders: Impact of symptoms, personality, and attachment Journal of Nervous and Mental Disease. 202: 64-69. DOI: 10.1097/NMD.0000000000000071  1
2014 Hedman AM, van Haren NEM, van Baal GCM, Brouwer RM, Brans RGH, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia Schizophrenia Research. DOI: 10.1016/j.schres.2015.06.021  1
2014 de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Steiner J, Rothermundt M, Leweke FM, van Beveren NJ, Kahn RS, Bahn S. Corrigendum to "Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment" [Schizophr. Res. 154 (1-3) (2014) 23-29] Schizophrenia Research. 157: 321. DOI: 10.1016/j.schres.2014.06.006  1
2014 Kahn R. Social neuroscience in psychiatry: Of obvious relevance World Psychiatry. 13: 147-148. DOI: 10.1002/wps.20124  1
2014 Kahn RS. Why Kraepelin was right: Schizophrenia as a cognitive disorder | Dlaczego Kraepelin mial racje: Schizofrenia jako zaburzenie poznawcze Neuropsychiatria I Neuropsychologia. 9: 41-47.  1
2014 Jahanshad N, Kochunov P, Nichols TE, Sprooten E, Mandl RC, Almasy L, Brouwer RM, Curran JE, De Zubicaray GI, Dimitrova R, Fox PT, Hong LE, Landman BA, Lemaitre H, Lopez L, ... ... Kahn RS, et al. Combining Meta- and mega-analytic approaches for multi-site diffusion imaging based genetic studies: From the enigma-DTI working group 2014 Ieee 11th International Symposium On Biomedical Imaging, Isbi 2014. 1234-1238.  1
2013 Degenhardt F, Priebe L, Meier S, Lennertz L, Streit F, Witt SH, Hofmann A, Becker T, Mössner R, Maier W, Nenadic I, Sauer H, Mattheisen M, Buizer-Voskamp J, Ophoff RA, et al. Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets. Translational Psychiatry. 3: e326. PMID 26151896 DOI: 10.1038/tp.2013.101  1
2013 Kennis M, Rademaker AR, van Rooij SJ, Kahn RS, Geuze E. Altered functional connectivity in posttraumatic stress disorder with versus without comorbid major depressive disorder: a resting state fMRI study. F1000research. 2: 289. PMID 25309726 DOI: 10.12688/f1000research.2-289.v2  1
2013 Mandl RC, Schnack HG, Zwiers MP, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging at 3 Tesla. Frontiers in Human Neuroscience. 7: 817. PMID 24409133 DOI: 10.3389/fnhum.2013.00817  1
2013 Jansma JM, van Raalten TR, Boessen R, Neggers SF, Jacobs RH, Kahn RS, Ramsey NF. fMRI guided rTMS evidence for reduced left prefrontal involvement after task practice. Plos One. 8: e80256. PMID 24376494 DOI: 10.1371/journal.pone.0080256  1
2013 van Nierop M, Janssens M, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D. Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk. Plos One. 8: e76690. PMID 24223116 DOI: 10.1371/journal.pone.0076690  1
2013 Luykx JJ, Bakker SC, van Geloven N, Eijkemans MJ, Horvath S, Lentjes E, Boks MP, Strengman E, DeYoung J, Buizer-Voskamp JE, Cantor RM, Lu A, van Dongen EP, Borgdorff P, Bruins P, ... Kahn RS, et al. Seasonal variation of serotonin turnover in human cerebrospinal fluid, depressive symptoms and the role of the 5-HTTLPR. Translational Psychiatry. 3: e311. PMID 24105442 DOI: 10.1038/tp.2013.84  1
2013 Hoogendam JM, Kahn RS, Hillegers MH, van Buuren M, Vink M. Different developmental trajectories for anticipation and receipt of reward during adolescence. Developmental Cognitive Neuroscience. 6: 113-24. PMID 24055865 DOI: 10.1016/j.dcn.2013.08.004  1
2013 de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophrenia Research. 150: 555-62. PMID 24051015 DOI: 10.1016/j.schres.2013.08.016  1
2013 Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, et al. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophrenia Research. 150: 328-33. PMID 24028744 DOI: 10.1016/j.schres.2013.07.058  1
2013 Bossong MG, Jansma JM, van Hell HH, Jager G, Kahn RS, Ramsey NF. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. Plos One. 8: e70074. PMID 23936144 DOI: 10.1371/journal.pone.0070074  1
2013 Stringer S, Derks EM, Kahn RS, Hill WG, Wray NR. Assumptions and properties of limiting pathway models for analysis of epistasis in complex traits. Plos One. 8: e68913. PMID 23935903 DOI: 10.1371/journal.pone.0068913  1
2013 Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Kahn RS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/ng.2711  0.68
2013 Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1687-97. PMID 23928295 DOI: 10.1016/j.euroneuro.2013.06.009  1
2013 Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. Jama Psychiatry. 70: 1107-12. PMID 23925787 DOI: 10.1001/jamapsychiatry.2013.155  1
2013 Lok A, Bockting CL, Koeter MW, Snieder H, Assies J, Mocking RJ, Vinkers CH, Kahn RS, Boks MP, Schene AH. Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression. Translational Psychiatry. 3: e288. PMID 23900311 DOI: 10.1038/tp.2013.60  0.6
2013 Mandl RC, Brouwer RM, Cahn W, Kahn RS, Hulshoff Pol HE. Family-wise automatic classification in schizophrenia. Schizophrenia Research. 149: 108-11. PMID 23876264 DOI: 10.1016/j.schres.2013.07.002  1
2013 Malchow B, Reich-Erkelenz D, Oertel-Knöchel V, Keller K, Hasan A, Schmitt A, Scheewe TW, Cahn W, Kahn RS, Falkai P. The effects of physical exercise in schizophrenia and affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 263: 451-67. PMID 23873090 DOI: 10.1007/s00406-013-0423-2  0.68
2013 Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies. Neuroscience and Biobehavioral Reviews. 37: 1587-96. PMID 23792047 DOI: 10.1016/j.neubiorev.2013.06.007  1
2013 den Braber A, Bohlken MM, Brouwer RM, van 't Ent D, Kanai R, Kahn RS, de Geus EJ, Hulshoff Pol HE, Boomsma DI. Heritability of subcortical brain measures: a perspective for future genome-wide association studies. Neuroimage. 83: 98-102. PMID 23770413 DOI: 10.1016/j.neuroimage.2013.06.027  1
2013 van den Heuvel MP, Sporns O, Collin G, Scheewe T, Mandl RC, Cahn W, Goñi J, Hulshoff Pol HE, Kahn RS. Abnormal rich club organization and functional brain dynamics in schizophrenia. Jama Psychiatry. 70: 783-92. PMID 23739835 DOI: 10.1001/jamapsychiatry.2013.1328  1
2013 Luykx JJ, Bakker SC, van Boxmeer L, Vinkers CH, Smeenk HE, Visser WF, Verhoeven-Duif NM, Strengman E, Buizer-Voskamp JE, de Groene L, van Dongen EP, Borgdorff P, Bruins P, de Koning TJ, Kahn RS, et al. D-amino acid aberrations in cerebrospinal fluid and plasma of smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2019-26. PMID 23615666 DOI: 10.1038/npp.2013.103  0.6
2013 Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychological Medicine. 43: 2571-82. PMID 23590895 DOI: 10.1017/S0033291713000226  1
2013 Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147: 132-9. PMID 23537477 DOI: 10.1016/j.schres.2013.03.001  1
2013 Diederen KM, Charbonnier L, Neggers SF, van Lutterveld R, Daalman K, Slotema CW, Kahn RS, Sommer IE. Reproducibility of brain activation during auditory verbal hallucinations. Schizophrenia Research. 146: 320-5. PMID 23465967 DOI: 10.1016/j.schres.2013.01.025  0.6
2013 Looijestijn J, Diederen KM, Goekoop R, Sommer IE, Daalman K, Kahn RS, Hoek HW, Blom JD. The auditory dorsal stream plays a crucial role in projecting hallucinated voices into external space. Schizophrenia Research. 146: 314-9. PMID 23453584 DOI: 10.1016/j.schres.2013.02.004  1
2013 Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Translational Psychiatry. 3: e234. PMID 23443360 DOI: 10.1038/tp.2013.6  1
2013 Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/JCP.0b013e3182856886  1
2013 van Gastel WA, MacCabe JH, Schubart CD, Vreeker A, Tempelaar W, Kahn RS, Boks MP. Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults. Psychological Medicine. 43: 2393-401. PMID 23414608 DOI: 10.1017/S0033291713000202  0.6
2013 van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196  1
2013 Vinkers CH, Zorn JV, Cornelisse S, Koot S, Houtepen LC, Olivier B, Verster JC, Kahn RS, Boks MP, Kalenscher T, Joëls M. Time-dependent changes in altruistic punishment following stress. Psychoneuroendocrinology. 38: 1467-75. PMID 23375639 DOI: 10.1016/j.psyneuen.2012.12.012  1
2013 Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 19: 479-94. PMID 23343917 DOI: 10.1177/1073858412472399  1
2013 Buizer-Voskamp JE, Blauw HM, Boks MP, van Eijk KR, Veldink JH, Hennekam EA, Vorstman JA, Mulder F, Tiemeier H, Uitterlinden AG, Kiemeney LA, van den Berg LH, Kahn RS, Sabatti C, Ophoff RA. Increased paternal age and the influence on burden of genomic copy number variation in the general population. Human Genetics. 132: 443-50. PMID 23315237 DOI: 10.1007/s00439-012-1261-4  1
2013 Luykx JJ, Boks MP, Breetvelt EJ, Aukes MF, Strengman E, da Pozzo E, Dell'osso L, Marazziti D, van Leeuwen A, Vreeker A, Abramovic L, Martini C, Numans ME, Kahn RS, Ophoff RA. BDNF Val66Met homozygosity does not influence plasma BDNF levels in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 43: 185-7. PMID 23269345 DOI: 10.1016/j.pnpbp.2012.12.017  1
2013 van Welie H, Derks EM, Verweij KH, de Valk HW, Kahn RS, Cahn W. The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder. Schizophrenia Research. 143: 354-7. PMID 23245702 DOI: 10.1016/j.schres.2012.11.011  0.68
2013 van Gastel WA, Tempelaar W, Bun C, Schubart CD, Kahn RS, Plevier C, Boks MP. Cannabis use as an indicator of risk for mental health problems in adolescents: a population-based study at secondary schools. Psychological Medicine. 43: 1849-56. PMID 23200103 DOI: 10.1017/S0033291712002723  0.6
2013 Diederen KM, Neggers SF, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IE. Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychological Medicine. 43: 1685-96. PMID 23199762 DOI: 10.1017/S0033291712002541  1
2013 Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 55-60. PMID 23193033 DOI: 10.1002/ajmg.b.32121  1
2013 Vreeker A, Schubart CD, van Gastel WA, Kahn RS, Boks MP. Advanced paternal age and vulnerability to psychotic-like experiences in the offspring. Schizophrenia Research. 143: 74-6. PMID 23182442 DOI: 10.1016/j.schres.2012.10.035  0.6
2013 Scheewe TW, Backx FJ, Takken T, Jörg F, van Strater AC, Kroes AG, Kahn RS, Cahn W. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatrica Scandinavica. 127: 464-73. PMID 23106093 DOI: 10.1111/acps.12029  0.68
2013 Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Social Psychiatry and Psychiatric Epidemiology. 48: 1289-95. PMID 23104669 DOI: 10.1007/s00127-012-0612-8  0.6
2013 Zandbelt BB, Bloemendaal M, Hoogendam JM, Kahn RS, Vink M. Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. Journal of Cognitive Neuroscience. 25: 157-74. PMID 23066733 DOI: 10.1162/jocn_a_00309  1
2013 Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bulletin. 39: 1129-38. PMID 23042112 DOI: 10.1093/schbul/sbs118  0.68
2013 Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Boos HB, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, Kahn RS. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biological Psychiatry. 73: 525-31. PMID 23039932 DOI: 10.1016/j.biopsych.2012.08.017  0.68
2013 Collin G, de Reus MA, Cahn W, Hulshoff Pol HE, Kahn RS, van den Heuvel MP. Disturbed grey matter coupling in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 46-54. PMID 23036782 DOI: 10.1016/j.euroneuro.2012.09.001  0.68
2013 Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2418-23. PMID 23000300 DOI: 10.1016/j.neubiorev.2012.09.006  1
2013 Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, Hulshoff Pol HE, Backx FJ, Kahn RS, Cahn W. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 675-85. PMID 22981376 DOI: 10.1016/j.euroneuro.2012.08.008  1
2013 Boos HB, Mandl RC, van Haren NE, Cahn W, van Baal GC, Kahn RS, Hulshoff Pol HE. Tract-based diffusion tensor imaging in patients with schizophrenia and their non-psychotic siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 295-304. PMID 22841128 DOI: 10.1016/j.euroneuro.2012.05.015  0.68
2013 van den Heuvel MP, van Soelen IL, Stam CJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic control of functional brain network efficiency in children. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 19-23. PMID 22819192 DOI: 10.1016/j.euroneuro.2012.06.007  0.56
2013 van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/j.psyneuen.2012.05.015  0.76
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/j.euroneuro.2012.04.019  1
2013 Mandl RC, Rais M, van Baal GC, van Haren NE, Cahn W, Kahn RS, Hulshoff Pol HE. Altered white matter connectivity in never-medicated patients with schizophrenia. Human Brain Mapping. 34: 2353-65. PMID 22461372 DOI: 10.1002/hbm.22075  1
2013 Zandbelt BB, Bloemendaal M, Neggers SF, Kahn RS, Vink M. Expectations and violations: delineating the neural network of proactive inhibitory control. Human Brain Mapping. 34: 2015-24. PMID 22359406 DOI: 10.1002/hbm.22047  1
2013 Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin. 39: 807-14. PMID 22282457 DOI: 10.1093/schbul/sbr195  1
2013 van Soelen IL, Brouwer RM, van Baal GC, Schnack HG, Peper JS, Chen L, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of volumetric brain changes and height in children entering puberty. Human Brain Mapping. 34: 713-25. PMID 22140022 DOI: 10.1002/hbm.21468  1
2013 de Weijer AD, Neggers SF, Diederen KM, Mandl RC, Kahn RS, Hulshoff Pol HE, Sommer IE. Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individuals. Human Brain Mapping. 34: 626-34. PMID 22109992 DOI: 10.1002/hbm.21463  0.64
2013 Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophrenia Bulletin. 39: 120-9. PMID 21746807 DOI: 10.1093/schbul/sbr069  1
2012 van Eijk KR, de Jong S, Boks MP, Langeveld T, Colas F, Veldink JH, de Kovel CG, Janson E, Strengman E, Langfelder P, Kahn RS, van den Berg LH, Horvath S, Ophoff RA. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. Bmc Genomics. 13: 636. PMID 23157493 DOI: 10.1186/1471-2164-13-636  1
2012 van Buuren M, Vink M, Kahn RS. Default-mode network dysfunction and self-referential processing in healthy siblings of schizophrenia patients. Schizophrenia Research. 142: 237-43. PMID 23099059 DOI: 10.1016/j.schres.2012.09.017  1
2012 Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, van den Berg LH, Ophoff RA. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biology. 13: R97. PMID 23034122 DOI: 10.1186/gb-2012-13-10-r97  1
2012 van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research. 141: 153-61. PMID 22981812 DOI: 10.1016/j.schres.2012.08.014  1
2012 Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/j.tips.2012.06.006  1
2012 de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. Plos One. 7: e39498. PMID 22761806 DOI: 10.1371/journal.pone.0039498  1
2012 van den Heuvel MP, Kahn RS, Goñi J, Sporns O. High-cost, high-capacity backbone for global brain communication. Proceedings of the National Academy of Sciences of the United States of America. 109: 11372-7. PMID 22711833 DOI: 10.1073/pnas.1203593109  1
2012 Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Archives of General Psychiatry. 69: 904-12. PMID 22566560 DOI: 10.1001/archgenpsychiatry.2012.191  1
2012 Luykx JJ, Vinkers CH, Bakker SC, Visser WF, van Boxmeer L, Strengman E, van Eijk KR, Lens JA, Borgdorff P, Keijzers P, Kappen TH, van Dongen EP, Bruins P, Verhoeven NM, de Koning TJ, ... Kahn RS, et al. A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2088-92. PMID 22549119 DOI: 10.1038/npp.2012.57  0.6
2012 Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 138: 171-6. PMID 22534419 DOI: 10.1016/j.schres.2012.03.036  0.68
2012 Scheewe TW, Takken T, Kahn RS, Cahn W, Backx FJ. Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia. Medicine and Science in Sports and Exercise. 44: 1834-42. PMID 22525773 DOI: 10.1249/MSS.0b013e318258e120  0.68
2012 Brouwer RM, Mandl RC, Schnack HG, van Soelen IL, van Baal GC, Peper JS, Kahn RS, Boomsma DI, Hulshoff Pol HE. White matter development in early puberty: a longitudinal volumetric and diffusion tensor imaging twin study. Plos One. 7: e32316. PMID 22514599 DOI: 10.1371/journal.pone.0032316  0.64
2012 Nieuwenhuis M, van Haren NE, Hulshoff Pol HE, Cahn W, Kahn RS, Schnack HG. Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage. 61: 606-12. PMID 22507227 DOI: 10.1016/j.neuroimage.2012.03.079  0.68
2012 Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, ... ... Kahn RS, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44: 552-61. PMID 22504417 DOI: 10.1038/ng.2250  0.32
2012 Hulshoff Pol HE, van Baal GC, Schnack HG, Brans RG, van der Schot AC, Brouwer RM, van Haren NE, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry. 69: 349-59. PMID 22474104 DOI: 10.1001/archgenpsychiatry.2011.1615  1
2012 Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychological Medicine. 42: 1903-11. PMID 22452790 DOI: 10.1017/S0033291712000062  1
2012 de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. European Journal of Human Genetics : Ejhg. 20: 1004-8. PMID 22433715 DOI: 10.1038/ejhg.2012.38  0.68
2012 Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychological Medicine. 42: 1847-56. PMID 22357376 DOI: 10.1017/S0033291712000098  1
2012 van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biological Psychiatry. 71: 915-21. PMID 22341827 DOI: 10.1016/j.biopsych.2012.01.010  1
2012 Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E, Kahn RS, Ramsey NF. Effects of δ9-tetrahydrocannabinol on human working memory function. Biological Psychiatry. 71: 693-9. PMID 22341370 DOI: 10.1016/j.biopsych.2012.01.008  1
2012 van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia Research. 137: 50-7. PMID 22313726 DOI: 10.1016/j.schres.2012.01.016  1
2012 Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, ... ... Kahn RS, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/journal.pone.0030497  1
2012 Aukes MF, Laan W, Termorshuizen F, Buizer-Voskamp JE, Hennekam EA, Smeets HM, Ophoff RA, Boks MP, Kahn RS. Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 338-41. PMID 22241106 DOI: 10.1016/gim.2011.16  0.6
2012 Boks MP, de Jong NM, Kas MJ, Vinkers CH, Fernandes C, Kahn RS, Mill J, Ophoff RA. Current status and future prospects for epigenetic psychopharmacology. Epigenetics : Official Journal of the Dna Methylation Society. 7: 20-8. PMID 22207355 DOI: 10.4161/epi.7.1.18688  1
2012 Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Premorbid school performance in twins concordant and discordant for bipolar disorder. Journal of Affective Disorders. 136: 294-303. PMID 22166398 DOI: 10.1016/j.jad.2011.11.034  1
2012 van Soelen IL, Brouwer RM, van Baal GC, Schnack HG, Peper JS, Collins DL, Evans AC, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic influences on thinning of the cerebral cortex during development. Neuroimage. 59: 3871-80. PMID 22155028 DOI: 10.1016/j.neuroimage.2011.11.044  1
2012 Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, Mehta MA, van Gerven JM, Kahn RS, Ramsey NF. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience. 24: 588-99. PMID 22066583 DOI: 10.1162/jocn_a_00156  1
2012 Breetvelt EJ, Numans ME, Aukes MF, Hoeben W, Strengman E, Luykx JJ, Bakker SC, Kahn RS, Ophoff RA, Boks MP. The association of the alpha-5 subunit of the nicotinic acetylcholine receptor gene and the brain-derived neurotrophic factor gene with different aspects of smoking behavior. Psychiatric Genetics. 22: 96-8. PMID 22008662 DOI: 10.1097/YPG.0b013e32834c0c75  0.6
2012 Hedman AM, van Haren NE, Schnack HG, Kahn RS, Hulshoff Pol HE. Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Human Brain Mapping. 33: 1987-2002. PMID 21915942 DOI: 10.1002/hbm.21334  0.28
2012 van Gastel WA, Wigman JT, Monshouwer K, Kahn RS, van Os J, Boks MP, Vollebergh WA. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction (Abingdon, England). 107: 381-7. PMID 21851445 DOI: 10.1111/j.1360-0443.2011.03626.x  0.6
2012 van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology. 219: 981-90. PMID 21822593 DOI: 10.1007/s00213-011-2428-8  1
2012 Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957  1
2012 van Rijn S, Swaab H, Baas D, de Haan E, Kahn RS, Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): evidence from fMRI. Social Cognitive and Affective Neuroscience. 7: 689-97. PMID 21737434 DOI: 10.1093/scan/nsr041  1
2012 Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 281-8. PMID 21733239 DOI: 10.1017/S1461145711000794  1
2012 van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology (Oxford, England). 26: 8-14. PMID 21730018 DOI: 10.1177/0269881111408964  0.68
2012 Luykx JJ, Laban KG, van den Heuvel MP, Boks MP, Mandl RC, Kahn RS, Bakker SC. Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neuroscience and Biobehavioral Reviews. 36: 198-205. PMID 21672551 DOI: 10.1016/j.neubiorev.2011.05.014  0.64
2012 Diederen KM, Daalman K, de Weijer AD, Neggers SF, van Gastel W, Blom JD, Kahn RS, Sommer IE. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophrenia Bulletin. 38: 1074-82. PMID 21527413 DOI: 10.1093/schbul/sbr033  1
2012 Boos HB, Cahn W, van Haren NE, Derks EM, Brouwer RM, Schnack HG, Hulshoff Pol HE, Kahn RS. Focal and global brain measurements in siblings of patients with schizophrenia. Schizophrenia Bulletin. 38: 814-25. PMID 21242319 DOI: 10.1093/schbul/sbq147  0.68
2012 Ziermans TB, Schothorst PF, Schnack HG, Koolschijn PC, Kahn RS, van Engeland H, Durston S. Progressive structural brain changes during development of psychosis. Schizophrenia Bulletin. 38: 519-30. PMID 20929968 DOI: 10.1093/schbul/sbq113  1
2012 van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/schbul/sbq062  1
2011 Collin G, Hulshoff Pol HE, Haijma SV, Cahn W, Kahn RS, van den Heuvel MP. Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Frontiers in Psychiatry. 2: 73. PMID 22203807 DOI: 10.3389/fpsyt.2011.00073  0.68
2011 Stringer S, Wray NR, Kahn RS, Derks EM. Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. Plos One. 6: e27964. PMID 22140493 DOI: 10.1371/journal.pone.0027964  1
2011 van den Heuvel MP, Kahn RS. Abnormal brain wiring as a pathogenetic mechanism in schizophrenia. Biological Psychiatry. 70: 1107-8. PMID 22115412 DOI: 10.1016/j.biopsych.2011.10.020  0.56
2011 Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ, Schughart K, Hovatta I. Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. Science Translational Medicine. 3: 102mr3. PMID 21957171 DOI: 10.1126/scitranslmed.3002917  1
2011 Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry. 70: 1151-8. PMID 21903198 DOI: 10.1016/j.biopsych.2011.07.028  1
2011 van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry. 68: 871-80. PMID 21893656 DOI: 10.1001/archgenpsychiatry.2011.88  1
2011 Boonstra G, Cahn W, Schnack HG, Hulshoff Pol HE, Minderhoud TC, Kahn RS, van Haren NE. Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophrenia Research. 132: 84-90. PMID 21835595 DOI: 10.1016/j.schres.2011.07.018  0.68
2011 Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/JCP.10m06529  1
2011 de Weijer AD, Mandl RC, Diederen KM, Neggers SF, Kahn RS, Hulshoff Pol HE, Sommer IE. Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophrenia Research. 130: 68-77. PMID 21641775 DOI: 10.1016/j.schres.2011.05.010  0.64
2011 Schubart CD, Sommer IE, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MP. Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophrenia Research. 130: 216-21. PMID 21592732 DOI: 10.1016/j.schres.2011.04.017  0.6
2011 van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. International Journal of Methods in Psychiatric Research. 20: 10-27. PMID 21574207 DOI: 10.1002/mpr.327  1
2011 van Buuren M, Vink M, Rapcencu AE, Kahn RS. Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry. 70: 81-7. PMID 21531384 DOI: 10.1016/j.biopsych.2011.03.011  0.92
2011 van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, Kahn RS. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophrenia Research. 129: 156-62. PMID 21497488 DOI: 10.1016/j.schres.2011.03.026  1
2011 Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophrenia Research. 129: 128-32. PMID 21489755 DOI: 10.1016/j.schres.2011.03.021  0.6
2011 van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, Kahn RS, Ramsey NF. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1377-88. PMID 21489346 DOI: 10.1017/S1461145711000526  1
2011 Somers M, Neggers SF, Diederen KM, Boks MP, Kahn RS, Sommer IE. The Measurement of Language Lateralization with Functional Transcranial Doppler and Functional MRI: A Critical Evaluation. Frontiers in Human Neuroscience. 5: 31. PMID 21483761 DOI: 10.3389/fnhum.2011.00031  0.6
2011 Daalman K, Boks MP, Diederen KM, de Weijer AD, Blom JD, Kahn RS, Sommer IE. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. The Journal of Clinical Psychiatry. 72: 320-5. PMID 21450152 DOI: 10.4088/JCP.09m05797yel  1
2011 Koning JP, Tenback DE, Kahn RS, Vollema MG, Cahn W, van Harten PN. Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis. Psychological Medicine. 41: 2141-7. PMID 21426602 DOI: 10.1017/S0033291711000389  0.68
2011 Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. Journal of Clinical Psychopharmacology. 31: 146-53. PMID 21346618 DOI: 10.1097/JCP.0b013e31820e3f58  0.68
2011 van Veelen NM, Vink M, Ramsey NF, Sommer IE, van Buuren M, Hoogendam JM, Kahn RS. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophrenia Research. 127: 195-201. PMID 21237617 DOI: 10.1016/j.schres.2010.12.013  1
2011 Schubart CD, Boks MP, Breetvelt EJ, van Gastel WA, Groenwold RH, Ophoff RA, Sommer IE, Kahn RS. Association between cannabis and psychiatric hospitalization. Acta Psychiatrica Scandinavica. 123: 368-75. PMID 21198455 DOI: 10.1111/j.1600-0447.2010.01640.x  0.6
2011 Slotema CW, Blom JD, de Weijer AD, Diederen KM, Goekoop R, Looijestijn J, Daalman K, Rijkaart AM, Kahn RS, Hoek HW, Sommer IE. Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biological Psychiatry. 69: 450-6. PMID 21144499 DOI: 10.1016/j.biopsych.2010.09.051  1
2011 Schubart CD, van Gastel WA, Breetvelt EJ, Beetz SL, Ophoff RA, Sommer IE, Kahn RS, Boks MP. Cannabis use at a young age is associated with psychotic experiences. Psychological Medicine. 41: 1301-10. PMID 20925969 DOI: 10.1017/S003329171000187X  0.6
2011 Magnée MJ, Kahn RS, Cahn W, Kemner C. More prolonged brain activity related to gaze cueing in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 506-11. PMID 20702135 DOI: 10.1016/j.clinph.2010.07.014  0.68
2011 Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry. 16: 442-51. PMID 20308993 DOI: 10.1038/mp.2010.26  1
2010 van den Heuvel MP, Mandl RC, Stam CJ, Kahn RS, Hulshoff Pol HE. Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15915-26. PMID 21106830 DOI: 10.1523/JNEUROSCI.2874-10.2010  0.64
2010 Diederen KM, De Weijer AD, Daalman K, Blom JD, Neggers SF, Kahn RS, Sommer IE. Decreased language lateralization is characteristic of psychosis, not auditory hallucinations. Brain : a Journal of Neurology. 133: 3734-44. PMID 21097491 DOI: 10.1093/brain/awq313  1
2010 Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Human Brain Mapping. 31: 1967-82. PMID 21086550 DOI: 10.1002/hbm.20991  1
2010 Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 855-65. PMID 20863671 DOI: 10.1016/j.euroneuro.2010.08.008  1
2010 van der Schot AC, Vonk R, Brouwer RM, van Baal GC, Brans RG, van Haren NE, Schnack HG, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Genetic and environmental influences on focal brain density in bipolar disorder. Brain : a Journal of Neurology. 133: 3080-92. PMID 20837502 DOI: 10.1093/brain/awq236  1
2010 Grootens KP, van Veelen NM, Sitskoorn MM, Sabbe BG, Peuskens J, Buitelaar JK, Verkes RJ, Kahn RS. Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 907-12. PMID 20833514 DOI: 10.1016/j.euroneuro.2010.08.003  0.44
2010 Vinkers CH, Mirza NR, Olivier B, Kahn RS. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Expert Opinion On Investigational Drugs. 19: 1217-33. PMID 20812877 DOI: 10.1517/13543784.2010.513382  0.6
2010 van Veelen NM, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophrenia Research. 123: 22-9. PMID 20724113 DOI: 10.1016/j.schres.2010.07.004  1
2010 de Weijer AD, Mandl RC, Sommer IE, Vink M, Kahn RS, Neggers SF. Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades. Frontiers in Human Neuroscience. 4: 41. PMID 20631846 DOI: 10.3389/fnhum.2010.00041  1
2010 van Lutterveld R, Oranje B, Kemner C, Abramovic L, Willems AE, Boks MP, Glenthøj BY, Kahn RS, Sommer IE. Increased psychophysiological parameters of attention in non-psychotic individuals with auditory verbal hallucinations. Schizophrenia Research. 121: 153-9. PMID 20494553 DOI: 10.1016/j.schres.2010.04.017  0.6
2010 van Veelen NM, Grootens KP, Peuskens J, Sabbe BG, Salden ME, Verkes RJ, Kahn RS, Sitskoorn MM. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophrenia Research. 120: 191-8. PMID 20493663 DOI: 10.1016/j.schres.2010.04.011  0.44
2010 Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 71: 520-7. PMID 20492850 DOI: 10.4088/JCP.09m05117yel  0.4
2010 Koolschijn PC, van Haren NE, Cahn W, Schnack HG, Janssen J, Klumpers F, Hulshoff Pol HE, Kahn RS. Hippocampal volume change in schizophrenia. The Journal of Clinical Psychiatry. 71: 737-44. PMID 20492835 DOI: 10.4088/JCP.08m04574yel  0.68
2010 Breetvelt EJ, Boks MP, Numans ME, Selten JP, Sommer IE, Grobbee DE, Kahn RS, Geerlings MI. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population. Schizophrenia Research. 120: 184-90. PMID 20421160 DOI: 10.1016/j.schres.2010.03.033  0.6
2010 Brans RG, Kahn RS, Schnack HG, van Baal GC, Posthuma D, van Haren NE, Lepage C, Lerch JP, Collins DL, Evans AC, Boomsma DI, Hulshoff Pol HE. Brain plasticity and intellectual ability are influenced by shared genes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5519-24. PMID 20410105 DOI: 10.1523/JNEUROSCI.5841-09.2010  1
2010 Zandi T, Havenaar JM, Smits M, Limburg-Okken AG, van Es H, Cahn W, Algra A, Kahn RS, van den Brink W. First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophrenia Research. 119: 27-33. PMID 20332065 DOI: 10.1016/j.schres.2010.02.1059  0.68
2010 Brouwer RM, Mandl RC, Peper JS, van Baal GC, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of DTI and MTR in nine-year-old children. Neuroimage. 53: 1085-92. PMID 20298793 DOI: 10.1016/j.neuroimage.2010.03.017  0.64
2010 Boks MP, Derks EM, Dolan CV, Kahn RS, Ophoff RA. "Forward genetics" as a method to maximize power and cost-efficiency in studies of human complex traits. Behavior Genetics. 40: 564-71. PMID 20232132 DOI: 10.1007/s10519-010-9348-y  0.6
2010 Van Haren NE, Koolschijn PC, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS. Cigarette smoking and progressive brain volume loss in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 454-8. PMID 20227855 DOI: 10.1016/j.euroneuro.2010.02.009  0.68
2010 van Soelen IL, Brouwer RM, Peper JS, van Beijsterveldt TC, van Leeuwen M, de Vries LS, Kahn RS, Hulshoff Pol HE, Boomsma DI. Effects of gestational age and birth weight on brain volumes in healthy 9 year-old children. The Journal of Pediatrics. 156: 896-901. PMID 20227719 DOI: 10.1016/j.jpeds.2009.12.052  1
2010 Luykx JJ, Boks MP, Terwindt AP, Bakker S, Kahn RS, Ophoff RA. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 357-68. PMID 20226637 DOI: 10.1016/j.euroneuro.2010.02.008  0.6
2010 Gaebel W, Riesbeck M, von Wilmsdorff M, Burns T, Derks EM, Kahn RS, Rössler W, Fleischhacker WW. Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 310-6. PMID 20202800 DOI: 10.1016/j.euroneuro.2010.02.001  1
2010 Diederen KM, Neggers SF, Daalman K, Blom JD, Goekoop R, Kahn RS, Sommer IE. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry. 167: 427-35. PMID 20123912 DOI: 10.1176/appi.ajp.2009.09040456  1
2010 van Buuren M, Gladwin TE, Zandbelt BB, Kahn RS, Vink M. Reduced functional coupling in the default-mode network during self-referential processing. Human Brain Mapping. 31: 1117-27. PMID 20108218 DOI: 10.1002/hbm.20920  1
2010 van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 153-63. PMID 20061126 DOI: 10.1016/j.euroneuro.2009.11.010  1
2010 Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/ajmg.b.31049  1
2009 Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. Plos One. 4: e6767. PMID 19774229 DOI: 10.1371/journal.pone.0006767  1
2009 Padmos RC, Van Baal GC, Vonk R, Wijkhuijs AJ, Kahn RS, Nolen WA, Drexhage HA. Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. Archives of General Psychiatry. 66: 957-65. PMID 19736352 DOI: 10.1001/archgenpsychiatry.2009.116  1
2009 Kemner C, Foxe JJ, Tankink JE, Kahn RS, Lamme VA. Abnormal timing of visual feedback processing in young adults with schizophrenia. Neuropsychologia. 47: 3105-10. PMID 19631672 DOI: 10.1016/j.neuropsychologia.2009.07.009  1
2009 van Buuren M, Gladwin TE, Zandbelt BB, van den Heuvel M, Ramsey NF, Kahn RS, Vink M. Cardiorespiratory effects on default-mode network activity as measured with fMRI. Human Brain Mapping. 30: 3031-42. PMID 19180557 DOI: 10.1002/hbm.20729  1
2008 Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, Ramsey NF, Vink M. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 42: 196-206. PMID 18538585 DOI: 10.1016/j.neuroimage.2008.04.183  1
2008 van Rijn S, Aleman A, Swaab H, Vink M, Sommer I, Kahn RS. Effects of an extra X chromosome on language lateralization: an fMRI study with Klinefelter men (47,XXY). Schizophrenia Research. 101: 17-25. PMID 18372164 DOI: 10.1016/j.schres.2008.02.001  1
2008 Baas D, Aleman A, Vink M, Ramsey NF, de Haan EH, Kahn RS. Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia. Neuroimage. 40: 719-27. PMID 18261933 DOI: 10.1016/j.neuroimage.2007.12.039  1
2007 Raemaekers M, Vink M, Zandbelt B, van Wezel RJ, Kahn RS, Ramsey NF. Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage. 36: 532-42. PMID 17499525 DOI: 10.1016/j.neuroimage.2007.03.061  1
2007 van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 16-23. PMID 16797166 DOI: 10.1016/j.euroneuro.2006.04.012  1
2006 Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Effects of aging on BOLD fMRI during prosaccades and antisaccades. Journal of Cognitive Neuroscience. 18: 594-603. PMID 16768362 DOI: 10.1162/jocn.2006.18.4.594  1
2006 van der Wee NJ, Hardeman HH, Ramsey NF, Raemaekers M, Van Megen HJ, Denys DA, Westenberg HG, Kahn RS. Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidity. Psychological Medicine. 36: 1321-6. PMID 16734943 DOI: 10.1017/S0033291706007926  1
2006 Vink M, Ramsey NF, Raemaekers M, Kahn RS. Striatal dysfunction in schizophrenia and unaffected relatives. Biological Psychiatry. 60: 32-9. PMID 16603134 DOI: 10.1016/j.biopsych.2005.11.026  1
2006 Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS. Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biological Psychiatry. 59: 530-5. PMID 16165103 DOI: 10.1016/j.biopsych.2005.07.030  1
2005 Vink M, Ramsey NF, Raemaekers M, Kahn RS. Negative priming in schizophrenia revisited. Schizophrenia Research. 79: 211-6. PMID 15978779 DOI: 10.1016/j.schres.2005.05.004  1
2005 Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Brain activation related to retrosaccades in saccade experiments. Neuroreport. 16: 1043-7. PMID 15973145 DOI: 10.1097/00001756-200507130-00003  1
2005 Vink M, Kahn RS, Raemaekers M, van den Heuvel M, Boersma M, Ramsey NF. Function of striatum beyond inhibition and execution of motor responses. Human Brain Mapping. 25: 336-44. PMID 15852388 DOI: 10.1002/hbm.20111  1
2005 Vink M, Kahn RS, Raemaekers M, Ramsey NF. Perceptual bias following visual target selection. Neuroimage. 25: 1168-74. PMID 15850734 DOI: 10.1016/j.neuroimage.2004.12.042  1
2004 van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. The American Journal of Psychiatry. 161: 2201-6. PMID 15569890 DOI: 10.1176/appi.ajp.161.12.2201  1
2004 Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophrenia Research. 68: 159-71. PMID 15099600 DOI: 10.1016/S0920-9964(03)00127-0  1
2003 van der Wee NJ, Ramsey NF, Jansma JM, Denys DA, van Megen HJ, Westenberg HM, Kahn RS. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage. 20: 2271-80. PMID 14683728 DOI: 10.1016/j.neuroimage.2003.05.001  1
2002 Sitskoorn MM, Nuyen J, Appels MC, van der Wee NJ, Kahn RS. Release from proactive inhibition in schizophrenia and its potential as a genotypic marker. Journal of Clinical and Experimental Neuropsychology. 24: 67-81. PMID 11935425 DOI: 10.1076/jcen.24.1.67.971  0.76
1992 Kahn RS, van Praag HM. Panic disorder: a biological perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 1-20. PMID 1638169 DOI: 10.1016/0924-977X(92)90031-3  1
1992 Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 106: 388-90. PMID 1533289 DOI: 10.1007/BF02245423  1
1992 Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43: 65-76. PMID 1438618 DOI: 10.1016/0165-1781(92)90142-P  1
1991 Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 37: 271-9. PMID 1891509 DOI: 10.1016/0165-1781(91)90063-U  1
1991 Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry. 30: 770-8. PMID 1751620 DOI: 10.1016/0006-3223(91)90233-C  1
1991 Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37: 25-34. PMID 1650487 DOI: 10.1016/0165-1781(91)90103-V  1
1990 Kahn RS, van Praag HM. Panic disorder: a presynaptic serotonin defect? Psychiatry Research. 31: 209-10. PMID 2326399 DOI: 10.1016/0165-1781(90)90123-M  1
1990 Wetzler S, Kahn RS, Cahn W, van Praag HM, Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Research. 31: 179-92. PMID 2326397 DOI: 10.1016/0165-1781(90)90120-T  1
1990 Kalus O, Kahn RS, Wetzler S, Asnis GM, van Praag HM. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biological Psychiatry. 28: 1053-7. PMID 2288999 DOI: 10.1016/0006-3223(90)90606-3  1
1990 Van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences. 600: 501-10. PMID 2252329  1
1990 Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Research. 33: 189-98. PMID 2243896 DOI: 10.1016/0165-1781(90)90073-E  1
1990 Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28: 358-62. PMID 2204434 DOI: 10.1016/0006-3223(90)90663-M  1
1990 Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology. 100: 339-44. PMID 2156278 DOI: 10.1007/BF02244603  1
1990 van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. The British Journal of Psychiatry : the Journal of Mental Science. 157: 723-34. PMID 1980627  1
1989 Kahn RS, Cahn W, van Praag HM. [Pathogenesis of panic disorders]. Nederlands Tijdschrift Voor Geneeskunde. 133: 498-501. PMID 2651934  1
1988 Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23: 189-208. PMID 3275471 DOI: 10.1016/0006-3223(88)90091-1  1
1988 Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research. 25: 101-4. PMID 3217461 DOI: 10.1016/0165-1781(88)90163-1  1
1988 van Praag HM, Kahn RS. L-5-hydroxytryptophan in depression and anxiety. Schweizerische Rundschau FüR Medizin Praxis = Revue Suisse De MéDecine Praxis. 77: 40-6. PMID 3055148  1
1988 Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 96: 360-4. PMID 2906153 DOI: 10.1007/BF00216062  1
1987 van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders. 13: 1-8. PMID 2959695 DOI: 10.1016/0165-0327(87)90067-X  1
1984 Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4  1
1982 Van Ree JM, Innemee H, Louwerens JW, Kahn RS, De Wied D. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine. Neuropharmacology. 21: 1095-101. PMID 6184639 DOI: 10.1016/0028-3908(82)90166-6  1
Show low-probability matches.